Moreover, cancer patients were characterized by a higher frequency of T cells co-expressing one or more inhibitory receptors and senescence markers, such as TIM-3, PD-1 and CD57 (Figures 2D,E and Supplementary Figures 3B, 4A–C). Here, HAVCR2 is linked to cancer.